Jazz Pharmaceuticals (JAZZ) Share-based Compensation (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted Share-based Compensation of $73.3 million for Q2 2026, up 13.6% from $64.5 million a year earlier but down 1.6% from the prior quarter.
Powered by 
Analysis
Jazz Pharmaceuticals (JAZZ) Share-based Compensation (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Jazz Pharmaceuticals was $306.73 million, up 17.0% year-over-year; for FY2025, it was $291.13 million, up 17.4% from FY2024.
- Annual Share-based Compensation has increased for seven consecutive years, with a five-year compound annual growth rate of 19.2% (FY2020 to FY2025).
- In prior years, Jazz Pharmaceuticals' Share-based Compensation was $248.05 million in FY2024 (+9.3%), $226.84 million in FY2023 (+2.2%), $222 million in FY2022 (+17.5%) and $189.01 million in FY2021 (+56.2%).
- Quarterly Share-based Compensation has run from a low of $50.07 million in Q1 2022 to a high of $88.08 million in Q3 2025 over five years.
- On a year-over-year basis, Share-based Compensation has increased in each of the last eight quarters, with growth averaging 16.9% over the last eight quarters.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q3 2021, with growth of 75.4%; the weakest was Q4 2023, with a decline of 14.0%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $74.5 million (Q1 2026), $70.85 million (Q4 2025) and $88.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Jazz Pharmaceuticals | 15.47 Bn | 9.29 Bn | 1.09 Bn | 73.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 73.30 Mn |
| Mar 31, 2026 | 74.50 Mn |
| Dec 31, 2025 | 70.85 Mn |
| Sep 30, 2025 | 88.08 Mn |
| Jun 30, 2025 | 64.50 Mn |
| Mar 31, 2025 | 67.70 Mn |
| Dec 31, 2024 | 70.19 Mn |
| Sep 30, 2024 | 59.76 Mn |
| Jun 30, 2024 | 56.65 Mn |
| Mar 31, 2024 | 61.44 Mn |
| Dec 31, 2023 | 52.94 Mn |
| Sep 30, 2023 | 56.12 Mn |
| Jun 30, 2023 | 61.43 Mn |
| Mar 31, 2023 | 56.35 Mn |
| Dec 31, 2022 | 61.56 Mn |
| Sep 30, 2022 | 56.68 Mn |
| Jun 30, 2022 | 53.69 Mn |
| Mar 31, 2022 | 50.07 Mn |
| Dec 31, 2021 | 53.12 Mn |
| Sep 30, 2021 | 53.24 Mn |
API Access
Jazz Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=JAZZ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "JAZZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=JAZZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();